These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30038008)

  • 1. Analysis of CD8
    Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.
    LaVergne SM; Sakabe S; Kanneh L; Momoh M; Al-Hassan F; Yilah M; Goba A; Sandi JD; Gbakie M; Cubitt B; Boisen M; Mayeux JM; Smira A; Shore K; Bica I; Pollard KM; Carlos de la Torre J; Branco LM; Garry RF; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Infect Dis; 2020 Oct; 222(9):1488-1497. PubMed ID: 32436943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus.
    Becquart P; Mahlakõiv T; Nkoghe D; Leroy EM
    PLoS One; 2014; 9(6):e96360. PubMed ID: 24914933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
    Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
    EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Common CD8
    Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
    Schweneker M; Laimbacher AS; Zimmer G; Wagner S; Schraner EM; Wolferstätter M; Klingenberg M; Dirmeier U; Steigerwald R; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.
    Ayouba A; Touré A; Butel C; Keita AK; Binetruy F; Sow MS; Foulongne V; Delaporte E; Peeters M
    J Clin Microbiol; 2017 Jan; 55(1):165-176. PubMed ID: 27795350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
    Wilson JA; Bray M; Bakken R; Hart MK
    Virology; 2001 Aug; 286(2):384-90. PubMed ID: 11485406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
    Thom R; Tipton T; Strecker T; Hall Y; Akoi Bore J; Maes P; Raymond Koundouno F; Fehling SK; Krähling V; Steeds K; Varghese A; Bailey G; Matheson M; Kouyate S; Coné M; Moussa Keita B; Kouyate S; Richard Ablam A; Laenen L; Vergote V; Guiver M; Timothy J; Atkinson B; Ottowell L; Richards KS; Bosworth A; Longet S; Mellors J; Pannetier D; Duraffour S; Muñoz-Fontela C; Sow O; Koivogui L; Newman E; Becker S; Sprecher A; Raoul H; Hiscox J; Henao-Restrepo AM; Sakoba K; Magassouba N; Günther S; Kader Konde M; Carroll MW
    Lancet Infect Dis; 2021 Apr; 21(4):507-516. PubMed ID: 33065039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
    Warfield KL; Olinger G; Deal EM; Swenson DL; Bailey M; Negley DL; Hart MK; Bavari S
    J Immunol; 2005 Jul; 175(2):1184-91. PubMed ID: 16002721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies.
    Ravichandran S; Khurana S
    EBioMedicine; 2022 Aug; 82():104186. PubMed ID: 35901660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West Africa.
    Colavita F; Biava M; Castilletti C; Lanini S; Miccio R; Portella G; Vairo F; Ippolito G; Capobianchi MR; Di Caro A; Lalle E
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31018522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic.
    Tipton TRW; Hall Y; Bore JA; White A; Sibley LS; Sarfas C; Yuki Y; Martin M; Longet S; Mellors J; Ewer K; Günther S; Carrington M; Kondé MK; Carroll MW
    Nat Commun; 2021 Feb; 12(1):1153. PubMed ID: 33608536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals.
    Herrera BB; Hamel DJ; Oshun P; Akinsola R; Akanmu AS; Chang CA; Eromon P; Folarin O; Adeyemi KT; Happi CT; Lu Y; Ogunsola F; Kanki PJ
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006530. PubMed ID: 29795572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge.
    Domi A; Feldmann F; Basu R; McCurley N; Shifflett K; Emanuel J; Hellerstein MS; Guirakhoo F; Orlandi C; Flinko R; Lewis GK; Hanley PW; Feldmann H; Robinson HL; Marzi A
    Sci Rep; 2018 Jan; 8(1):864. PubMed ID: 29339750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced
    Chabot S; Gimie Y; Obeid K; Kim J; Meseda CA; Konduru K; Kaplan G; Sheng Fowler L; Weir JP; Peden K; Major ME
    J Virol; 2022 Sep; 96(18):e0116621. PubMed ID: 36069549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein.
    Li D; Li P; Song N; Jiang Y; Zeng Y; Zhao G; Fa Y; Ye H; Lone Y; Zhou Y; Sun S; Zeng L
    Microbes Infect; 2019; 21(1):56-62. PubMed ID: 29775667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins.
    Koch T; Rottstegge M; Ruibal P; Gomez-Medina S; Nelson EV; Escudero-Pérez B; Pillny M; Ly ML; Koundouno FR; Bore JA; Magassouba N; Dahlke C; Günther S; Carroll MW; Addo MM; Muñoz-Fontela C
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32825479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study.
    Halfmann PJ; Eisfeld AJ; Watanabe T; Maemura T; Yamashita M; Fukuyama S; Armbrust T; Rozich I; N'jai A; Neumann G; Kawaoka Y; Sahr F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007654. PubMed ID: 31369554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.